LandisKGriffethMDPhD

PubMed

• 6 citations
  Utility of whole-body (head-to-toe) PET/CT in the evaluation of melanoma and sarcoma patients.
  Heather R. Webb, Hamid R. Latifi, Landis K. Griffeth> ;Nuclear Medicine Communications. 2018 Jan 1
• 55 citations
  Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.
  Hossein Jadvar, Patrick M. Colletti, Roberto Delgado-Bolton, G. Esposito, Bernd J. Krause, Andrei Iagaru, Helen Nadel, David I. Quinn, Eric M. Rohren, Rathan M. Subram...> ;Journal of Nuclear Medicine. 2017 Dec 1
• 8 citations
  Optimal interpretative strategy for preoperative parathyroid scintigraphy.
  Farshad Michael Bahador, Hamid R. Latifi, Stanley J. Grossman, Umesh Oza, Hui Xu, Landis K. Griffeth> ;Clinical Nuclear Medicine. 2015 Feb 1
• 1 citations
  Positron Emission Tomography for Subsequent Treatment Strategy in Oncology
  Landis K. Griffeth, Bruce E. Hillner, Anthony F. Shields, Barry A. Siegel> ;Journal of Clinical Oncology. 2014 Sep 1
• 4 citations
  Facelift and Patterns of Lymphatic Drainage
  Ricardo A. Meade, Sumeet S. Teotia, Landis K. Griffeth, Fritz E. Barton> ;Aesthetic Surgery Journal. 2012 Jan 1
• 1 citations
  Visualization of discrete sacral foramina as an ancillary sign of superscan.
  Leeanne K. Harshman, Hamid R. Latifi, Landis K. Griffeth> ;Clinical Nuclear Medicine. 2011 Jan 1
• 4 citations
  PET imaging today: contribution to the initial staging and prognosis of patients with non-Hodgkin's lymphomas.
  Tanvir Sattar, Landis K. Griffeth, Hamid R. Latifi, Jonathan D. Glass, Reinhold Munker, David L Lilien> ;The Journal of the Louisiana State Medical Society. 2006 Jul 1
• 118 citations
  Use of PET/CT scanning in cancer patients: technical and practical considerations.
  Landis K. Griffeth> ;Proceedings. 2005 Oct 1
• 1 citations
  Oncologic positron emission tomography: a surgical perspective.
  Todd O. Moore, Landis K. Griffeth> ;Proceedings. 2003 Jan 1
• 53 citations
  FDG-PET evaluation of indeterminate pancreatic masses.
  Chi-lai Ho, Farrokh Dehdashti, Landis K. Griffeth, Paul E. Buse, Dennis M. Balfe, Barry A. Siegel> ;Journal of Computer Assisted Tomography. 1996 May 1
• 40 citations
  Pharmacokinetics of nitroxide NMR contrast agents.
  Landis K. Griffeth, Gerald M. Rosen, Elmer J. Rauckman, Burton P. Drayer> ;Investigative Radiology. 1984 Nov 1
• 1 citations
  Effect of acute cocaine administration on the metabolism of antipyrine in vivo.
  Michelle W. Kloss, Landis K. Griffeth, Gerald M. Rosen, Elmer J. Rauckman> ;Biochemical Pharmacology. 1983 Dec 15
• Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin''s disease.
  Munker, R., Glass, J., Griffeth, L. K., Sattar, T., Zamani, R., Heldmann, M., Shi, R., Lilien, D. L.> ;Ann Oncol. 2004 Nov
• Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose.
  Dehdashti, F., Siegel, B. A., Griffeth, L. K., Fusselman, M. J., Trask, D. D., McGuire, A. H., McGuire, D. J.> ;Radiology. 1996 Jul
• Brain metastases from non-central nervous system tumors: evaluation with PET.
  Griffeth, L. K., Rich, K. M., Dehdashti, F., Simpson, J. R., Fusselman, M. J., McGuire, A. H., Siegel, B. A.> ;Radiology. 1993 Jan
• Results of a clinical receiver operating characteristic study comparing filtered backprojection and maximum likelihood estimator images in FDG PET studies.
  Llacer, J., Veklerov, E., Baxter, L. R., Grafton, S. T., Griffeth, L. K., Hawkins, R. A., Hoh, C. K., Mazziotta, J. C., Hoffman, E. J., Metz, C. E.> ;J Nucl Med. 1993 Jul
• Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.
  Dehdashti, F., Mortimer, J. E., Siegel, B. A., Griffeth, L. K., Bonasera, T. J., Fusselman, M. J., Detert, D. D., Cutler, P. D., Katzenellenbogen, J. A., Welch, M. J.> ;J Nucl Med. 1995 Oct
• Effects of model traumatic injury on hepatic drug metabolism in the rat. III. Differential responses of cytochrome P-450 subpopulations.
  Griffeth, L. K., Rosen, G. M., Rauckman, E. J.> ;Drug Metab Dispos. 1984 Sep 01
• Effects of model traumatic injury on hepatic drug metabolism in the rat. II. In vivo metabolism of hexobarbital and zoxazolamine.
  Griffeth, L. K., Rosen, G. M., Rauckman, E. J.> ;Drug Metab Dispos. 1984 Sep 01
• Effects of model traumatic injury on hepatic drug metabolism in the rat. I. In vivo antipyrine metabolism.
  Griffeth, L. K., Rosen, G. M., Tschanz, C., Rauckman, E. J.> ;Drug Metab Dispos. 1983 Nov 01
• Intrathecal administration of nitroxides as potential contrast agents for MR imaging.
  Rosen, G. M., Griffeth, L. K., Brown, M. A., Drayer, B. P.> ;Radiology. 1987 Apr 01
• Effects of model traumatic injury on hepatic drug metabolism in the rat. VI. Major detoxification/toxification pathways.
  Griffeth, L. K., Rosen, G. M., Rauchman, E. J.> ;Drug Metab Dispos. 1987 Nov 01
• Effects of model traumatic injury on hepatic drug metabolism in the rat. V. Sulfation and acetylation.
  Griffeth, L. K., Rosen, G. M., Rauckman, E. J.> ;Drug Metab Dispos. 1985 Jul 01
• Effects of model traumatic injury on hepatic drug metabolism in the rat. IV. Glucuronidation.
  Griffeth, L. K., Rosen, G. M., Rauckman, E. J.> ;Drug Metab Dispos. 1985 Jul 01
• Sex-dependent differences in N-(3-[18F]fluoropropyl)-N-nordiprenorphine biodistribution and metabolism.
  Chesis, P. L., Griffeth, L. K., Mathias, C. J., Welch, M. J.> ;J Nucl Med. 1990 Feb
• Join now to see all